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ABSTRACT 
Dyslipidemia is a condition marked by unhealthy abnormal concentrations of lipids in blood. 
There is no direct description of dyslipidemia in Ayurvedic texts. However Medo Rogas (fat 
disorders) are described in Ayurvedic texts since ancient times. Dyslipidemia (Medo roga) is a 
disease of diminished Jatharagni, Bhutagni and Dhatwagni induced Apachita or Saam Asthayi 
Meda Dhatu Vriddhi. So for the management of Dyslipidemia (Medo roga) such drugs are needed 
which having Deepan, Pachan, Kaphaghna and Medoghna properties. In this regards it is time 
essential to classify them by considering its specific therapeutic effect and not only by using as an 
indistinct lipid lowering agent. Aim: To review the properties and action of Ayurvedic lipid 
lowering herbs against specific involved Samprapti Ghatak (pathological factor) in the 
management of Dyslipidemia (Medo roga). Result: Study provides good evidence of classification 
of Ayurvedic lipid lowering herbs in the management of Dyslipidemia (Medo roga). 
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INTRODUCTION 
Dyslipidemia is a condition marked by 
unhealthy abnormal concentrations of lipids in blood. 
Latest studies have reported that increased 
cholesterol level is present in 25–30% of urban and 
15–20% rural population. It is a major risk factor for 
many life threatening disorders like atherosclerotic 
cardio and cerebro vascular disorders (ASCVD). It has 
been closely linked to the patho-physiology of ASCVD 
and Dyslipidemia is a key independent modifiable 
risk factor.[1,2] In India the burden of ASCVD is 
alarmingly high and usually gets the disease at early 
age with more severe form with poor outcome.[3] By 
virtue of this importance it is rationale to provide 
safe and effective management for Dyslipidemia.  
Now research interest has focused on various 
Ayurvedic herbs for their potential role in lipid 
lowering properties. Herbal medicines are used as 
single and compound formulations or along with 
minerals. Many Ayurvedic herbo-mineral 
formulations are processed in herbal juices to 
increase the potency of formulation. Phytochemical 
and pharmological studies are in course to 
ascertaining the lipid lowering properties of many 
herbal plants described in Ayurveda text from last 
few decades. Clinical studies also have reported that 
Ayurvedic herbal medicines are effective in lowering 
LDL-C.[4] Hence reexploring the rich heritage of 
herbal medicines of Ayurveda is essential by 
extensively conducting the preclinical studies and 
randomized controlled trials. But while using rich 
heritage of Ayurveda for clinical purpose one should 
not neglect the concept of Agni, Dosha Dhatu and 
Strotogamitva of herbs.  
AIM: To review the properties and action of 
Ayurvedic lipid lowering herbs against specific 
involved Samprapti Ghatak (pathological factor) in 
the management of Dyslipidemia (Medo roga).  
MATERIALS AND METHODS 
Literature of Ayurveda and research 
evidences was reviewed, along with taking into 
consideration of their active principles and 
pharmacological properties. Understandings of 
Dyslipidemia were discussed as per Ayurveda system 
of medicine and Ayurvedic lipid lowering herbs were 
classified on the basis of principle of Ayurveda and 
pharmacological research studies.  
Dyslipidemia (Medoroga) 
There is no direct description of dyslipidemia 
or hyperlipidemia in Ayurvedic texts. However Medo 
Dhatu Rogas (disorders) are described in Ayurvedic 
texts since ancient times. Excessive accumulation of 
Meda in body causes various diseases like Medoroga 
or Sthaulya or Atisthaulya, Granthi, Galaganda and 
Madhumeha.[5] 
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Correlation of Etiological factors of Dyslipidemia 
(Medo roga) 
Dyslipidemia have varied type of etiological 
factors. Apart from congenital types (i.e. type I, IIa, III 
and IV) various acquired types are also found in the 
development of lipid disorders. Acquired etiological 
factors are most commonly found in the development 
of lipid disorders than congenital. Acquired factors 
are obesity, diabetes mellitus, physical inactivity, 
alcoholism, hypothyroidism, nephrotic syndrome, 
cholestatic liver disease etc.[6]  
As per Ayurveda, Medodhatu has immediate 
relationship with Rakta Dhatu in terms that Prasad 
Bhaag produced during metabolism of Rakta Dhatu 
nourishes Meda Dhatu. Rakta Dhatu is responsible for 
transportation of Asthayi Meda Dhatu (circulating 
lipids) to all over body tissue. Pathogenesis of 
Madhumeha (Diabetes mellitus) states that the prime 
involvement of Meda Dhatu in disease formation[7] 
Vrikka and Vapavahan are the Moola sthana of 
Medovaha strotas.[8] Hence there is involvement of 
Vrikka in Meda dhatu vikaras (lipid disorders). Liver 
is the main site for formation and processing of lipids. 
Dyslipidemia (Medo Roga) is the common feature in 
various liver disorders. Alcohol consumption is 
vitiating factor for Medo Dhatu Vikara.[9] After critical 
study of both modern and Ayurvedic literature it may 
be stated that Medo roga may have involvement of 
Tridosha, Rakta Dhatu (blood tissue), Yakrit (liver), 
Vrikka (kidney) and Vapavahan (omentum). 
Concept of Dyslipidemia in Ayurveda 
The term Medo Dhatu described in Ayurveda 
covers fats, lipid and adipose tissue; hence the 
disorders of these tissues can be considered as 
disorders of Meda dhatu. As per Ayurveda Medoroga 
involved Kapha dosha and Meda dhatu as a prime 
causative factor and Vata and Pitta are responsible 
for fatal complications.[10,11] Acharyas particularly 
mentioned if Meda is increased in very moderate 
quantity in body and remains untreated for long 
period may cause death of patient.[12]  
On the basis of physiological consideration of 
Meda dhatu, circulating lipids are considered as 
Asthayi (Poshak) Dhatu and where as body fats or 
adipose tissue can be considered as Sthayi or Sthira 
Meda Dhatu. The term lipid is better to consider in 
relation to physiological aspect of fat where as 
adipose tissue to be considered in relation to 
anatomical aspect. In Medo Rogas all the etiological 
factors influence and disturb (Agnimandya) the 
Jatharagni primarily and then consequently Bhutagni 
and Dhatwagni, which causes excess formation of 
Apaachit or Saam Meda Dhatu. From above 
discussion it may be stated that Obesity (Sthoulya) is 
a disease of Apaachit or Saam Sthayi medo dhatu 
Vriddhi and Dyslipidemia (Medo roga) is a disease of 
Apaachit or Saam Asthayi Meda Dhatu Vriddhi.  
Management Principle for Dyslipidemia (Medo 
Roga) 
Dyslipidemia (Medo roga) is a disease of 
diminished Jatharagni and Dhatwagni induced 
Apachita or Saam Asthayi Meda Dhatu Vriddhi. 
Bhutagni is the link between Jatharagni and 
Dhatwagni, means all three Agni are diminished. So 
for the management of Dyslipidemia (Medo roga) 
such drugs are needed which having Deepan, Pachan, 
Kaphaghna and Medoghna properties. Acharya 
Charak advises to use Guru and Apatarpan medicines, 
which are having Shleshma-Medohara properties and 
Vataghna diet in the management of Atisthaulya. 
Various treatment modalities like diet and life style 
modification, conservative treatment and 
Panchkarma procedures are mentioned in Ayurveda 
for management of Medo Rogas.[13] Beside these, wide 
varieties of causes of Dyslipidemia (Medo roga) 
connote the use of specific lipid lowering drugs as per 
the etiological factors. For the effective management 
of lipid disorders it is mandatory to use such drug 
which has potential pharmacological action on exact 
etiological factor. 
Pharmological and clinical studies have 
reported that Ayurvedic herbal medicines are 
effective in lowering LDL-C.[14] Ayurvedic lipid 
lowering herbs are depicted as per their 
pharmacological action at specific pathogenesis level. 
So while managing Dyslipidemia (Medo roga) specific 
herbs has to be used as per the various causative 
acquired factors.  
In this regards it is time essential to classify 
them by considering its specific therapeutic effect 
and not only by using as a indistinct lipid lowering 
agent. It is rationale to use Ayurvedic lipid lowering 
herbs against specific involved Samprapti Ghatak 
(pathological factor) in the management of 
Dyslipidemia (Medo roga).  
Drug useful in Dyslipidemia (Medo roga) might 
have below properties 
1) Drug must have Deepan, Paachan properties with 
Ushna Virya (potency). 
2) It has action on all varieties of Agni i.e. Jatharagni 
(GIT level), Bhutagni (Hepatic metabolism level) 
and Dhatwagni (various body tissue metabolism 
level). 
3) It has capacity to digest the Rasa Rakta gata 
apaachit saam Meda. 
4) It has to be safe for long term use. 
5) At the same time it also minimizes the future 
complications by the property of Urjaskar 
(Rasayan and Vrishya).  
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Classification of enlisted Ayurvedic lipid lowering 
herbs according principle of Ayurveda  
On these backgrounds after in depth study for 
classification of Ayurvedic lipid lowering herbs 
principles of Samhitas, qualities and pharmacological 
actions mentioned in various Nighantus and 
pharmacological research evidences are taken in 
consideration. We try to classify it according to 
therapeutic effect at various level of Samprapti 
Ghatak (pathological factor) of Dyslipidemia (Medo 
roga). 
Table 1: Classification of Ayurvedic herbs according to disease condition 
S. No. Disease Condition Useful Herbs 
1. 
Obesity (Sthoulya) - 
Apaachit or Saam Sthayi 
medo dhatu vriddhi  
Guggulu (Commiphora mukul)[15], Vidanga (Embelia ribes)[16], Triphala 
(Three fruits) [17], Amara Bela (Cuscuta reflexa). [18] 
2. 
Dyslipidemia (Medo roga) 
Apaachit or Saam asthayi 
meda dhatu vriddhi 
Jeerak (Cuminum cyminum) [19], Guduchi (Tinospora cordifolia) [20], 
Amalaki (Emblica officinalis) [21], Chavya (Piper chaba) [22], Haridra 
(Curcuma longa) [23], Musta (Cyperus rotundus) [23], Arjun (Terminalia 
arjuna) [24], Palandu (Allium cepa) [25], Erandamoola (Ricinus 
communis root). [26] 
Table 2: Classification of Ayurvedic herbs based on their therapeutic properties 
S.No. Samprapti Level Therapeutic Action  Lipid Lowering Herbs 
1 Jatharagni Agni Deepan, Paachan 
Chavya (Piper chaba) [22] 
Jeerak (Cuminum cyminum) [19] 
Trikatu (Three peppers) [27] 
Sunthi (Zinziber officinale) [28] 
2 Bhutagni 
Bhutagni deepan (Agni + 
Vaayu) 
Kutki (Picrorhiza kurroa) [29]  
Bhringraj (Eclipta alba) [30]  
Bhunimba (Andrograhis paniculata) [31] 





3.1 Rasa dhatu 
Rasa Dhatwagni Deepan, 
Paachan 
Chavya (Piper chaba) [22] 
Jeerak (Cuminum cyminum) [19] 
Trikatu (Three peppers) [27] 
Arjun (Terminalia arjuna) [24] 
3.2 Rakta Dhatu 
Rakta Dhatwagni Deepan, 
Paachan 
Kutki (Picrorhiza kurroa) [29] 
Bhringraj (Eclipta alba) [30] 
Bhunimba (Andrograhis paniculata) [31] 
Patola (Trichosanthes dioica) [33]  
Sariva (Hemidesmus indicus) [34]  
Haridra (Curcuma longa) [23] 
3.3 Mamsa Dhatu 
Mamsa Dhatwagni Deepan, 
Paachan 
Nimba (Melia azadirachta) [35]  
Triphala (Three fruits) [17] 
Musta (Cyperus rotundus) [23] 




Kirattikta (Swertia chirata) [36]  
Sunthi (Zinziber officinale) [28]  
Guduchi (Tinospora cordifolia) [20]  
Rasona (Allium sativum) [37] 
Eranda moola (Ricinus communis root) [26] 
4 Upadhatu 
Paachan + Dhatwagni 
deepan 
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4.1 
Rasa – Stanya  Jeerak (Cuminum cyminum) [19] 
- Asruj  Kumari (Aloe vera) [38] 
4.2 
Rakta - Sira  Kutki (Picrorhiza kurroa) [29] 
- Kandara  Eranda (Ricinus communis) [26] 
4.3 
Mamsa- Vasa  Sunthi (Zinziber officinale) [28] 
- Shat Tvacha  
Sariva (Hemidesmus indicus) [34] 
Vidanga (Embelia ribes) [16]  
Chopchini (Smilax china) [39] 
Guduchi (Tinospora cordifolia)  
Karanj (Pongamia pinnata) [40] 
4.4 
Meda – Snayu  
Sunthi (Zinziber officinale) [28]  
Eranda moola (Ricinus communis) [26] 
- Sandhaya  
Guggulu (Commiphora mukul) [41]  
Sunthi (Zinziber officinale) [28]  
Rasona (Allium sativum) [37]  
Eranda moola (Ricinus communis root) [26] 
DISCUSSION 
Classification of Ayurvedic lipid lowering herbs 
according to research evidences  
Herbal plant lowers lipid by virtue of various 
pharmacological actions exerts by their active 
constituents i.e. saponins, tannins, alkaloids, alkenyl 
phenols, glycol-alkaloids, flavonoids, sesquiterpenes 
lactones, terpenoids and phorbol esters.[42] As per the 
pharmacological research evidences, herbs may be 
classified on their properties like LDL lowering, HDL 
elevating, inhibition of HMG CoA reductase enzyme 
and LDL oxidation property.  
Herbs like Lomaphala (Passiflora foetida), 
Chakramard (Cassia tora seeds), Shunthi (Zingiber 
officinale rhizome), Bhunimba (Andrographis 
paniculata leaves), Mandukparni (Centella asiatica 
leaves), Kembuka (Costus speciosus), Methika 
(Trigonella foenum-graecum seeds), Isabgol (Plantago 
ovata seeds)are having low density lipoprotein 
lowering property.[43-47] 
Some herbs are possessing both LDL lowering 
and HDL elevating properties like Ajamoda (Apium 
graveolens seeds), Bilva (Aegle marmelos leaves), 
Sarshap (Brassica juncea seeds), Erandakarkati 
(Carica papaya fruit), Vidanga (Embelia ribes fruits), 
Mundi (Sphaeranthus indicus), Khadira (Acacia 
catechu leaf), Amar bela (Cuscuta reflexa), Guggulu 
(Commiphora mukul gum resin) and Kalonji (Nigella 
Sativa Seeds).[43,48-51] 
Research studies investigate that herbs are 
also having statin like properties of inhibition of HMG 
CoA reductase enzyme. It decreases cholesterol 
synthesis by inhibition of rate limiting HMG CoA 
reductase enzyme. These herbs are Plaksha (Ficus 
virens bark), Lodhra (Symplocos racemosa bark), 
Amalaki (Emblica officinalis fruits), Ashok (Polyalthia 
longifolia leaves) and Alabu (Lagenaria siceraria).[43]  
Oxidative damage by free radicals has been 
concerned as the ground of diverse diseases. 
Numerous evidence from the conducted studies put 
forward that oxidation of LDL plays a key role in 
pathogenesis of atherosclerosis. Tulsi (Ocimum 
basilicum), Kanchanar (Bauhinia variegate flower), 
Haridra (Curcuma longa rhizome), Teela (Sesamum 
indicum seeds), Avartaki (Cassia auriculata leaves) 
and Draksha (Vitis vinifera fruit) are lowers lipids by 
acting on LDL oxidation.[43,52,53]  
Some herbs are versatile in properties having 
LDL lowering, HDL elevating and LDL oxidation 
properties like Jamun (Syzygium cumini seeds) and 
Samudrashoka (Salvia officinalis leaves). Lahsuna 
(Allium sativum fruits) lowers lipids by all above 
properties.[43] 
CONCLUSION 
Each drug has specific pharmacological 
actions like some herbs are acting on Jatharagni, 
some on Bhutagni, some on Dhatwagni, some directly 
acting on Meda dhatu and at many more level as per 
Ayurveda. Study provides good evidence of 
classification of Ayurvedic lipid lowering herbs in the 
management of Dyslipidemia (Medo roga) as per 
Ayurveda and research evidences. 
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